Over the last five years, the use of plasma exchange in autoallergic disease has moved from being an ad hoc approach to the treatment of a few cases of a rare, fulminating and often fatal disease, known to be due to circulating autoantibody, to providing a means for treating and investigating the pathogenesis of many forms of renal and nonrenal disease. While its ultimate role in patient management is still uncertain, the groups of patients likely to benefit from it are becoming better defined.
Nephritis, which is responsible for the majority of cases of end-stage renal failure, may result from one of two immunopathological mechanisms: the deposition of immune complexes, responsible for the majority of clinical and histopathological subtypes of nephritis or, more rarely, the attachment of specific autoantibody directed at the antigenic determinants of the glomerular basement membrane (GBM); this latter, the so-called antiglomerular basement membrane disease, is frequently responsible for the clinical entity of Goodpasture's syndrome (lung haemorrhage and nephritis). While it is clear from experimental evidence that immune complexes or specific autoantibodies are the initiators of glomerular injury, the target organ damage is principally mediated by the many humoral and cellular factors involved in the inflammatory response.
Plasma exchange (Pinching 1978} provides the opportunity for control of a hostile internal macromolecular environment, either by the selective depletion of abnormal substances and excessive levels of normal plasma factors (by exchange with fresh-frozen plasma), or by the depletion of all plasma proteins except albumin (by exchanging for plasma protein fraction) (Lockwood, Pussell et al. 1979) . While the former manipulation is more precise and restricted in its effects, the more extensive alterations produced by the latter, with the concomitant removal of not only the pathogenetic initiators but also the humoral mediators of injury, are a desirable double-edged weapon in fulminating autoallergic disease. In particular, the removal of complement components, clotting factors, kinins, etc., is likely to have an immediate and significant anti-inflammatory action.
The use of plasma exchange alone in treatment is rarely justified, for while the effects are rapid and striking they are likely to be short-lived unless the generation of the abnormal humoral factors can be controlled or their peripheral inflammatory effects modified. Herein lies the justification for combin-o141-{)768j 79j06039~3j$0 1.00jO ing plasma exchange with immunosuppressive agents and corticosteroids. The immunosuppressive agents used -cyclophosphamide and/or azathioprine -are intended to suppress the generation of autoantibody, or the antibody component of immune complexes, reducing pathogenicity by altering their physical characteristics; in addition, these agents have a powerful antiinflammatory effect which in the short term may be more important than their immunosuppressive properties. Corticosteroids may, in high dosage, have some immunosuppressive effect by altering the distribution of lymphocytes, but their predominant role is anti-inflammatory.
There are three major subgroups of glomerulonephritis in which plasma exchange regimes have been used: antiglomerular basement membrane antibody-mediated nephritis (with or without lung haemorrhage); the other forms of rapidly progressive glomerulonephritis, usually seen in the context of systemic disease such as polyatteritis or Wegener's granulomatosis; and severe lupus nephritis.
Antiglomerular basement membrane disease causing rapidly progressive nephritis has previously been associated with a very poor prognosis, most patients developing irreversible renal failure or dying of lung haemorrhage with no discernible benefit from steroid or immunosuppressive regimes. The results following introduction of plasma exchange are strikingly different; in four and a half years we have treated 26 patients with anti-GBM disease using a regime of plasma exchange, immunosuppression and steroids (Lockwood et al. 1976 , Rees et al. 1979 . Pulmonary haemorrhage resolved in 18 of 19 cases, the only failure being in a patient with widespread infection and having only 3 days of treatment before death. Patients with rapidly deteriorating renal function at the start of treatment had this trend reversed and renal function slightly improved in 10 of 11 patients. The single failure of treatment in the latter group was again a patient with infection and inadequate plasma exchange (due to vascular access problems). III a few patients in whom a late deterioration in renal function occurred or lung haemorrhage recurred following cessation of plasma exchange, the reintroduction of plasma exchange alone led to resolution of target organ damage. Six patients had stable impaired renal function before therapy and renal function was maintained in all, while evidence of active nephritis resolved. Nephritis which had already resulted in anuria was however never seen to recover (0/13). Similar experience has been described from another centre (Kincaid-Smith & d'Apice 1978) .
Two reports, both on small numbers of patients, have been published indicating less than satisfactory results with plasma exchange in other units. In one of these (McLeish et at. 1978) , the number and frequency of plasma exchanges was less than what we now regard as essential for immediate control of the autoantibody. After an initial resolution of active disease and recovery of renal function (inappropriately attributed to clearance of creatinine by plasma exchange), the patient showed a late deterioration in renal function associated with low but significant levels of antibody in the circulation; further treatment was not undertaken and may explain the 'failure' of treatment. In the second report (Swainson et al. 1978) , 2 patients were oliguric and the third was initially treated by plasma exchange without steroids or immunosuppression until after renal function had been lost.
The conclusion from our own studies and those of the Melbourne group is that a regime of intensive daily plasma exchange combined with immunosuppressive and steroid therapy is effective when introduced early in patients with antiglomerular basement membrane antibody disease. The duration of intensive treatment must be determined entirely by evidence of cessation of target organ damage; the levels of circulating antibody will only give a rough guide to the efficacy of immunosuppression. In patients with end-stage renal failure, continuing high levels of antibody warn of the possibility of lung haemorrhage. Transplantation is contraindicated until the antibody has disappeared, as anti-OBM disease has a striking tendency to recur in the graft. In two recent reports concerning transplantation in the presence of anti-OBM antibodies, the graft was either temporarily retrieved (Swainson et al. 1978) or recurrence 'prevented' (Cove-Smith et al. 1978) by intensive plasma exchange. There seems to be no risk of recurrent nephritis in patients with anti-OBM disease who are transplanted after the disappearance of antibody.
Patients with rapidly progressive nephritis not associated with circulating antibodies frequently have direct or indirect evidence of circulating immune complexes as the initiating pathogenetic factor. In almost every case seen in our unit, detailed assessment has shown that this form of nephritis is associated with multisystem disease myopathy, peripheral neuropathy, arthropathy, episcleritis, etc.-sufficient to justify a diagnosis of polyarteritis or, in cases with major respiratory involvement, of Wegener's granulomatosis. This heterogeneity has made assessment of therapy difficult and some patients in these categories have been seen to respond to corticosteroids and immunosuppressive regimes. Following encouraging results in a pilot study of plasma exchange, immunosuppression and corticosteroids in patients of this sort , we have set up a controlled clinical trial of steroids and immunosuppressives with or without plasma exchange to evaluate the additional benefit, if any, from plasma exchange. This study is not yet complete; however, the pilot study suggested that both the rate of improvement and the increment in renal function were greater with plasma exchange than without. This response of other aspects of the systemic disease was similar.
In our experience, the duration of plasma exchange required by patients with rapidly progressive nephritis or the immune complex type is less than that needed by patients with anti-OBM disease, as judged by the period taken before evidence of active target organ damage is absent, probably reflecting different size of tissue pools of the initiators of injury. It is probable that plasma exchange, as well as physically removing immune complexes (Pussell et al. 1978) , may enhance the capability of the reticuloendothelial system for their clearance (Lockwood, Worrledge et al. 1979). Patients in this group of diseases tend to have a more pronounced acute phase response than those with anti-OBM disease, and so plasma exchange will also have a substantial role as an antiinflammatory agent by its ability to deplete these mediators of tissue damage.
In lupus nephritis, it is more difficult to evaluate new forms of treatment largely because of the spontaneous fluctuations in the disease or changes associated with infections and their resolution, and also because of delayed responses to other treatments, especially steroids. It is probable that only in severe cases, poorly responsive to conventional treatment regimes, is plasma exchange justifiable. We have studied 7 such patients with diffuse proliferative lupus nephritis, all of whom had significant degrees of renal failure; in 3 patients steroids (with or without immunosuppressives) were introduced simultaneously with plasma exchange, while in 4 patients plasma exchange was added after steroids had failed to control disease. In all but one patient there was clear evidence of improvement which appeared to correlate with the introduction of plasma exchange regimes. The rate of improvement in the face of severe disease in the 3 treated concurrently was unusually rapid, suggesting that plasma exchange had some adjuvant effect. While it is likely that the improvement in 3 of the other 4 was due to the introduction of exchange, it is impossible to exclude alternative explanations. The improvement seen in these patients was associated with the disappearance of circulating immune complexes detected by the C 1 binding assay and the return of other clinical and serological evidence of disease activity towards normal (Pussell et at. 1978) .
While plasma exchange has been performed in other forms of nephritis, the patients studied were too diverse to enable firm conclusions to be drawn. It seems that the more indolent forms of nephritis are not, in general, responsive to plasma exchange.
In patients with rapidly progressive nephritis, whether or not due to anti-GHM antibodies, we have noted a striking frequency of relapses associated with infection (Rees et at. 1977, and unpublished observations) . It is becoming clear that the enhancement of tissue injury in immunologically-mediated disease following infection is a widespread phenomenon and may indeed underlie the natural history of some forms of nephritis. The increase in inflammatory mediators occurring in such infections may be responsible for the amplification of target organ damage where organs have already been 'marked out' by the initiators of injury. It is clearly important that exacerbating factors, especially infection, must be carefully documented in any evaluation of these diseases and their treatment. Furthermore, the increased risk of infection associated with steroid and immunosuppressive agents is a significant hazard of their use.
While patients with rapidly progressive nephritis or lupus nephritis form a minority of patients with glomerulonephritis, it is clear that regimes including plasma exchange can make a major contribution to reversing or preventing severe renal failure in these cases. It is less certain whether these techniques will be directly applicable to patients with the more chronic forms of nephritis. However, there is no doubt that many of the lessons learnt about the natural history of less common, more aggressive forms of nephritis can illuminate the pathogenetic mechanisms in other forms of renal disease as well as in other immunologically-mediated diseases.
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General practinoners, especially those living on their practice premises, are natural audiences for the proud parent's orations about the achievements of their offspring. So it was that late in the 1950s, a proud mother, talking about her child's prowess at the local school, casually merrtioned the names of four other children, also in the same practice, who regularly vied with her child for the exalted position at the top of the form. Later that day, the antenatal records of the children's mothers were studied and one common feature was observed-they had all received progesterone during the first trimester of that pregnancy for the relief of pregnancy symptoms, such as headaches, vomiting, depression and tiredness. One question had to be answered: 'Could the progesterone be responsible for the intelligence of these children?'
To test this possibility, 32 children aged 6-13 years, whose mothers had received progesterone, were selected from the practice records. These children will be called 'progesterone children'. An equal number of controls were matched for age, social class and parity, and with the permission of the local education officer, the head teachers were given an unmarked list of names and asked to grade them into average, above average and below average. The assessment showed 55 0 0 of the progesterone children above average compared with 41o~of controls (Dalton 1968) .
After that pilot study a more ambitious survey was started. Between 1955and 1958the author had worked at the City of London Maternity Hospital as a research assistant, selecting antenatal patients with pregnancy symptoms and treating them with progesterone to successfully reduce the incidence of pre-eclamptic toxaemia from 10 0 0 to 3 0 0 (Dalton 1957). Thus, ten years later, the hospital
